Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Joern Rau"'
Autor:
Pablo Martinez-Martin, Guenther Deuschl, Lisa Tonder, Alfons Schnitzler, Jean-Luc Houeto, Lars Timmermann, Joern Rau, Carmen Schade-Brittinger, Valerie Stoker, Marie Vidailhet, Paul Krack, EARLYSTIM Study Group
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237498 (2020)
The EARLYSTIM Study compared deep brain stimulation (DBS) with best medical treatment (BMT) over 2-years, showing a between-group difference of 8.0 from baseline in favor of DBS in health-related quality of life (HRQoL), measured with the PDQ-39 SI (
Externí odkaz:
https://doaj.org/article/6ada9061104f4287869494fe6f273f69
Autor:
Jacobus Pfisterer, Florence Joly, Gunnar Kristensen, Joern Rau, Sven Mahner, Patricia Pautier, Ahmed El-Balat, Jean-Emmanuel Kurtz, Ulrich Canzler, Jalid Sehouli, Martin L. Heubner, Andreas D. Hartkopf, Klaus Baumann, Annette Hasenburg, Lars C. Hanker, Antje Belau, Barbara Schmalfeldt, Dominik Denschlag, Tjoung-Won Park-Simon, Frédéric Selle, Christian Jackisch, Alexander Burges, Hans-Joachim Lück, Günter Emons, Werner Meier, Martina Gropp-Meier, Willibald Schröder, Nikolaus de Gregorio, Felix Hilpert, Philipp Harter
PURPOSE To compare standard versus extended duration of bevacizumab treatment in combination with front-line chemotherapy in women with newly diagnosed stage IIB-IV ovarian cancer. METHODS In this multicenter, open-label, randomized phase III trial (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c13b29794f39e0be755b18faba7687
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85147092420
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85147092420
Autor:
Jacobus Pfisterer, Joern Rau
Publikováno v:
Journal of Clinical Oncology. 41:1953-1954
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbcde35213434b482ea6c1af3dda33d4
https://doi.org/10.1200/jco.23.00063
https://doi.org/10.1200/jco.23.00063
Autor:
Valerie Stoker, Frank Steigerwald, Günther Deuschl, Domenic J. Reda, Joern Rau, Kenneth A. Follett, Ping Luo, Lisa Tonder, Frances M. Weaver, Steffen Paschen
Publikováno v:
Journal of Neurosurgery. 132:1376-1384
OBJECTIVESeveral randomized studies have compared the effect of deep brain stimulation (DBS) of the subthalamic nucleus with the best medical treatment in large groups of patients. Important outcome measures differ between studies. Two such major stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c350067484c46bf7141fd269dfdf24cb
https://doi.org/10.3171/2018.12.jns182042
https://doi.org/10.3171/2018.12.jns182042
Autor:
Inken Tödt, Bassam Al‐Fatly, Oliver Granert, Andrea A. Kühn, Paul Krack, Joern Rau, Lars Timmermann, Alfons Schnitzler, Steffen Paschen, Ann‐Kristin Helmers, Andreas Hartmann, Eric Bardinet, Michael Schuepbach, Michael T. Barbe, Till A. Dembek, Valerie Fraix, Dorothee Kübler, Christine Brefel‐Courbon, Alireza Gharabaghi, Lars Wojtecki, Marcus O. Pinsker, Stephane Thobois, Philippe Damier, Tatiana Witjas, Jean‐Luc Houeto, Carmen Schade‐Brittinger, Marie Vidailhet, Andreas Horn, Günther Deuschl
Publikováno v:
Movement Disorders
Movement Disorders, 2022, ⟨10.1002/mds.28952⟩
Tödt, Inken; Al-Fatly, Bassam; Granert, Oliver; Kühn, Andrea A; Krack, Paul; Rau, Joern; Timmermann, Lars; Schnitzler, Alfons; Paschen, Steffen; Helmers, Ann-Kristin; Hartmann, Andreas; Bardinet, Eric; Schuepbach, Michael; Barbe, Michael T; Dembek, Till A; Fraix, Valerie; Kübler, Dorothee; Brefel-Courbon, Christine; Gharabaghi, Alireza; Wojtecki, Lars; ... (2022). The Contribution of Subthalamic Nucleus Deep Brain Stimulation to the Improvement in Motor Functions and Quality of Life. Movement disorders, 37(2), pp. 291-301. Wiley 10.1002/mds.28952
Movement Disorders, 2022, ⟨10.1002/mds.28952⟩
Tödt, Inken; Al-Fatly, Bassam; Granert, Oliver; Kühn, Andrea A; Krack, Paul; Rau, Joern; Timmermann, Lars; Schnitzler, Alfons; Paschen, Steffen; Helmers, Ann-Kristin; Hartmann, Andreas; Bardinet, Eric; Schuepbach, Michael; Barbe, Michael T; Dembek, Till A; Fraix, Valerie; Kübler, Dorothee; Brefel-Courbon, Christine; Gharabaghi, Alireza; Wojtecki, Lars; ... (2022). The Contribution of Subthalamic Nucleus Deep Brain Stimulation to the Improvement in Motor Functions and Quality of Life. Movement disorders, 37(2), pp. 291-301. Wiley 10.1002/mds.28952
BACKGROUND Subthalamic nucleus deep brain stimulation (STN-DBS) effectively treats motor symptoms and quality of life (QoL) of advanced and fluctuating early Parkinson's disease. Little is known about the relation between electrode position and chang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a282ea8279f90bc02c833161872fe74
https://hal.sorbonne-universite.fr/hal-03559813/document
https://hal.sorbonne-universite.fr/hal-03559813/document
Autor:
Paul Krack, Alfons Schnitzler, Günther Deuschl, Joern Rau, Lisa Tonder, Valerie Stoker, Gillian Barnett, Carmen Schade-Brittinger, Lars Timmermann, Marie Vidailhet, Jean-Luc Houeto, Isabelle Durand-Zaleski
Publikováno v:
Stoker, Valerie; Krack, Paul; Tonder, Lisa; Barnett, Gillian; Durand-Zaleski, Isabelle; Schnitzler, Alfons; Houeto, Jean-Luc; Timmermann, Lars; Rau, Joern; Schade-Brittinger, Carmen; Vidailhet, Marie; Deuschl, Günther (2020). Deep Brain Stimulation Impact on Social and Occupational Functioning in Parkinson's Disease with Early Motor Complications. Movement disorders clinical practice, 7(6), pp. 672-680. Wiley 10.1002/mdc3.13015
Movement Disorders Clinical Practice
Movement Disorders Clinical Practice
Background Deep brain stimulation (DBS) improves motor symptoms and quality of life in patients with Parkinson's disease (PD) and early motor complications, suggesting that DBS could be prescribed to the working‐age PD population. Objectives To inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3c7f1b94347cb12f0bee8aba0cf0190
Autor:
Jacobus Pfisterer, Catherine M Shannon, Klaus Baumann, Joern Rau, Philipp Harter, Florence Joly, Jalid Sehouli, Ulrich Canzler, Barbara Schmalfeldt, Andrew P Dean, Alexander Hein, Alain G Zeimet, Lars C Hanker, Thierry Petit, Frederik Marmé, Ahmed El-Balat, Rosalind Glasspool, Nikolaus de Gregorio, Sven Mahner, Tarek M Meniawy, Tjoung-Won Park-Simon, Marie-Ange Mouret-Reynier, Cristina Costan, Werner Meier, Alexander Reinthaller, Jeffrey C Goh, Tifenn L'Haridon, Sally Baron Hay, Stefan Kommoss, Andreas du Bois, Jean-Emmanuel Kurtz, Sven Ackermann, Christoph Anthuber, Mustafa Aydogdu, Angelika Baldauf, Wolfgang Bauer, Dirk Behringer, Antje Belau, Alexandra Bender, Cosima Brucker, Alexander Burges, Trygve Daabach, Dominik Denschlag, Mustafa Deryal, Steffen Dörfel, Juliane Ebert, Tanja Fehm, Susanne Maria Feidicker, Gabriele Feisel-Schwickardi, Ricardo Felberbaum, Matthias Frank, Gerhard Gebauer, Bernd Gerber, Axel Gerhardt, Andrea Grafe, Martin Griesshammer, Eva-Maria Grischke, Isolde Gröll, Martina Gropp-Meier, Dietrich Hager, Volker Hanf, Carla Verena Hannig, Peer Hantschmann, Tanja Hauzenberger, Uwe Herwig, Martin Heubner, Carsten Hielscher, Felix Hilpert, Thomas Hitschold, Manfred Hofmann, Christian Jackisch, Wolfgang Janni, Ludwig Kiesel, Yon-Dschun Ko, Hans-Joachim Koch, Petra Krabisch, Peter Krieger, Thomas Kubin, Thorsten Kühn, Björn Lampe, Peter Ledwon, Sabine Lemster, Benno Lex, Clemens Liebrich, Ralf Lorenz, Hans-Joachim Lück, Peter Mallmann, Wolfgang Meinerz, Götz Menke, Volker Möbus, Thomas Müller, Volker Müller, Tanja Neunhöffer, Angelika Ober, Gülten Oskay-Özcelik, Horst Ostertag, Martin Pölcher, Beate Rautenberg, Daniel Rein, Wilhelm Reiter, Andreas Rempen, Ingo Runnebaum, Marcus Schmidt, Sabine Schnohr, Heinz Scholz, Willibald Schröder, Eike Simon, Antje Sperfeld, Annette Steckkönig, Hans-Georg Strauß, Ronaldo Stuth, Jürgen Terhaag, Falk Thiel, Marc Thill, Oliver Tomé, Christoph Uleer, Susanne Vogel, Hermann Voß, Michael Weigel, Ulrich Winkler, Arthur Wischnik, Tobias Zeiser, Andreas Zorr, Ros Glasspool, Emma Hudson, Rachel Jones, Judith Lafleur, Christian Marth, Edgar Petru, Yoland Antill, Mary Azer, Sally Baron-Hay, Philip Beale, Stephen Begbie, Allison Black, Karen Briscoe, Andrew Dean, Jeffrey Goh, Sandra Harvey, Chee Lee, Marco Matos, Tarek Meniawy, Inger Olesen, Catherine Shannon, Paul Vasey, Sophie Abadie-Lacourtoisie, Olivier Arsene, Sophie Barthier, Célia Becuwe-Roemer, Dominique Berton-Rigaud, Maria Cappiello-Bataller, Stéphanie Catala, Francesco Del Piano, Gaël Deplanque, Raymond Despax, Nadine Dohollou, Claire Garnier-Tixidré, Julien Grenier, Emmanuel Guardiola, Anne-Claire Hardy-Bessard, Claudia Lefeuvre-Plesse, Marianne Leheurteur, Anne Lesoin, Charles-Briac Levache, Raffaele Longo, Alain Lortholary, Jérôme Meunier, Nadia Raban, Olivier Romano, Jean-Michel Vannetzel, Alain Zannetti
Publikováno v:
Lancet Oncology
Lancet Oncology, 2020, 21 (5), pp.699-709. ⟨10.1016/S1470-2045(20)30142-X⟩
The Lancet Oncology
The Lancet Oncology, 2020, 21 (5), pp.699-709. ⟨10.1016/S1470-2045(20)30142-X⟩
Lancet Oncology, 2020, 21 (5), pp.699-709. ⟨10.1016/S1470-2045(20)30142-X⟩
The Lancet Oncology
The Lancet Oncology, 2020, 21 (5), pp.699-709. ⟨10.1016/S1470-2045(20)30142-X⟩
Background:\ud State-of-the art therapy for recurrent ovarian cancer suitable for platinum-based re-treatment includes bevacizumab-containing combinations (eg, bevacizumab combined with carboplatin–paclitaxel or carboplatin–gemcitabine) or the mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6dcdfeb9666bdc098f5e231578e0974
https://hal.science/hal-02887894
https://hal.science/hal-02887894
Autor:
Stéphane Thobois, Marie Vidailhet, Stéphane Derrey, Andrea Kistner, Philippe Damier, Daniel Weiss, W.M. Michael Schuepbach, Günther Deuschl, Thomas D. Hälbig, Tobias Wächter, Andreas Kupsch, Michael T. Barbe, Jan Vesper, Carmen Schade-Brittinger, Christine Brefel-Courbon, G.R. Fink, Jean-Luc Houeto, Friederike Sixel-Döring, Alireza Gharabaghi, Jens Volkmann, Karina Knudsen, David Maltête, Andrea A. Kühn, Andrea Falk, Patrick Mertens, Gerd-H. Schneider, Lars Timmermann, Alfons Schnitzler, Eric Seigneuret, Fabienne Ory-Magne, Pascal Derkinderen, Patrick Chaynes, Tatiana Witjas, Joern Rau, Valérie Fraix, S. Paschen, J. Regis, Lisa Tonder, Lars Wojtecki, Marcus O. Pinsker, Paul Krack, Haidar S. Dafsari, Andreas Hartmann, Fanny Pineau, Laura Paschen, Claudia Trenkwalder, Yves Agid
Publikováno v:
Neurology
Neurology, American Academy of Neurology, 2019, 92 (10), pp.e1109-e1120. ⟨10.1212/WNL.0000000000007037⟩
Neurology 92(10), e1109 (2019). doi:10.1212/WNL.0000000000007037
Schüpbach, Michael; Tonder, Lisa; Schnitzler, Alfons; Krack, Paul; Rau, Joern; Hartmann, Andreas; Hälbig, Thomas D; Pineau, Fanny; Falk, Andrea; Paschen, Laura; Paschen, Stephen; Volkmann, Jens; Dafsari, Haidar S; Barbe, Michael T; Fink, Gereon R; Kühn, Andrea; Kupsch, Andreas; Schneider, Gerd-H; Seigneuret, Eric; Fraix, Valerie; ... (2019). Quality of life predicts outcome of deep brain stimulation in early Parkinson disease. Neurology, 92(10), e1109-e1120. American Academy of Neurology 10.1212/WNL.0000000000007037
Neurology, American Academy of Neurology, 2019, 92 (10), pp.e1109-e1120. ⟨10.1212/WNL.0000000000007037⟩
Neurology 92(10), e1109 (2019). doi:10.1212/WNL.0000000000007037
Schüpbach, Michael; Tonder, Lisa; Schnitzler, Alfons; Krack, Paul; Rau, Joern; Hartmann, Andreas; Hälbig, Thomas D; Pineau, Fanny; Falk, Andrea; Paschen, Laura; Paschen, Stephen; Volkmann, Jens; Dafsari, Haidar S; Barbe, Michael T; Fink, Gereon R; Kühn, Andrea; Kupsch, Andreas; Schneider, Gerd-H; Seigneuret, Eric; Fraix, Valerie; ... (2019). Quality of life predicts outcome of deep brain stimulation in early Parkinson disease. Neurology, 92(10), e1109-e1120. American Academy of Neurology 10.1212/WNL.0000000000007037
ObjectiveTo investigate predictors for improvement of disease-specific quality of life (QOL) after deep brain stimulation (DBS) of the subthalamic nucleus (STN) for Parkinson disease (PD) with early motor complications.MethodsWe performed a secondary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b969db51fa582ea76be80aafe3e5ac17
https://hal-normandie-univ.archives-ouvertes.fr/hal-02373051
https://hal-normandie-univ.archives-ouvertes.fr/hal-02373051
Autor:
Nicoletta Colombo, Antonio González-Martín, Petronella B. Ottevanger, Lydie Bastiere-Truchot, Sandra Polleis, Anne Floquet, Isabel Bover, Maria Bjurberg, Christian Marth, Ignace Vergote, Domenica Lorusso, Carmen Schade-Brittinger, Andreas du Bois, Sven Mahner, Josep M. del Campo, Nicolas Martin, Astrid Kiermaier, Mikkel Z. Oestergaard, Patricia Pautier, Christian Kurzeder, Frederik Marmé, Joern Rau, Pilar Barretina-Ginesta
Purpose The AGO-OVAR 2.29/ENGOT-ov14/PENELOPE prospectively randomized phase III trial evaluated the addition of pertuzumab to chemotherapy in patients with platinum-resistant ovarian carcinoma with low tumor human epidermal growth factor receptor 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fad8a2a45ca299f3ca71e16c850cc444
http://hdl.handle.net/10281/129111
http://hdl.handle.net/10281/129111
Autor:
Dominique Berton-Rigaud, Frédéric Selle, Nicolas Martin, Sven Mahner, Josep M. del Campo, Angiolo Gadducci, Antonio González-Martín, Frederik Marmé, Christian Kurzeder, Astrid Kiermaier, Petronella B. Ottevanger, Eugenia Ortega, Lydie Bastiere-Truchot, Y. García, Andreas du Bois, Patricia Pautier, Nicoletta Colombo, Joern Rau
ObjectiveIn platinum-resistant ovarian cancer, adding pertuzumab to gemcitabine improved progression-free survival in the subgroup with low tumor HER3 messenger RNA expression. The 2-part PENELOPE trial (NCT01684878) is prospectively investigating pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27b6d11a1e51b4d7113e74d6caffadc4
http://hdl.handle.net/11568/843357
http://hdl.handle.net/11568/843357